KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Receivables: 2009-2024

Historic Receivables for Bausch Health Companies (BHC) over the last 16 years, with Dec 2024 value amounting to $2.1 billion.

  • Bausch Health Companies' Receivables rose 15.43% to $2.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $8.8 billion, marking a year-over-year increase of 7.24%. This contributed to the annual value of $2.1 billion for FY2024, which is 7.11% up from last year.
  • Per Bausch Health Companies' latest filing, its Receivables stood at $2.1 billion for FY2024, which was up 7.11% from $2.0 billion recorded in FY2023.
  • In the past 5 years, Bausch Health Companies' Receivables ranged from a high of $2.1 billion in FY2024 and a low of $1.6 billion during FY2020.
  • Moreover, its 3-year median value for Receivables was $2.0 billion (2023), whereas its average is $2.0 billion.
  • In the last 5 years, Bausch Health Companies' Receivables dropped by 14.25% in 2020 and then rose by 12.56% in 2021.
  • Bausch Health Companies' Receivables (MRY) stood at $1.6 billion in 2020, then grew by 12.56% to $1.8 billion in 2021, then increased by 0.85% to $1.8 billion in 2022, then increased by 11.62% to $2.0 billion in 2023, then increased by 7.11% to $2.1 billion in 2024.
  • Its last three reported values are $2.1 billion in FY2024, $2.0 billion for FY2023, and $1.8 billion during FY2022.